研报掘金丨华鑫证券：三星医疗海外订单高增长，予“买入”评级

Core Viewpoint - Samsung Medical achieved significant growth in overseas revenue, indicating strong market expansion and order growth, particularly in Europe and emerging markets [1] Group 1: Overseas Revenue Growth - The company reported overseas revenue of 1.495 billion yuan in the first half of the year, representing a year-on-year increase of 51% [1] - Key breakthroughs in overseas distribution were made in Europe, the Middle East, and Latin America, with initial orders secured in Hungary, Romania, and Kyrgyzstan in the first half of 2025 [1] Group 2: Order Backlog - The total order backlog for the company reached 17.632 billion yuan, reflecting a year-on-year growth of 18.39% [1] - The overseas distribution order backlog amounted to 2.182 billion yuan, showing a substantial year-on-year increase of 123.96% [1] Group 3: Strategic Initiatives - The company is focusing on high-end markets and emerging regions, enhancing its presence in North America and Africa [1] - A new sales company was established in Hungary to support the expansion of overseas distribution business [1]